measuring pain intensity. Their work was stimulated by an evolving understanding of pain physiology. Previously, pain had been thought to be the end-point of an overstimulation of any of the recognised sensory mechanisms, but by 1939 it was realised that pain had its own neurological pathways and was likely to have its own peripheral receptors and cerebral centres 2,3 . Hardy and colleagues devised a dolorimeter, a device which focused light on a blackened area of skin and produced a painful stimulus at 113°F 4 . Later they devised a scoring system to record the intensity of pain experienced: "Twentyone discriminable intensities of pain were observed between the threshold pain and the ceiling pain...a scale of pain intensity is proposed, the unit of which is called a 'dol', composed of 2 just perceptible steps in discrimination of stimulus intensity" 5 .
In 1951, the "Hardy-Wolff-Goodell dolorimeter" was used for the first time on patients in an attempt to assess the effectiveness of analgesia during labour. Nineteen patients were enrolled in this trial which involved producing painful stimuli with the dolorimeter after each contraction and asking the patient to compare the pain with the pain of the previous contraction. Apparently "...reproducible comparisons could be made as the pains increased (or decreased) during labor". It did not prove to be a useful tool in this setting: "...[one] patient became so hostile that attempts at further measurements were abandoned...this failure to obtain valid measurements was due mainly to an unwillingness on the part of the patient to cooperate" 6 . And another patient understandably resented "...the necessity of feeling the pain twice".
Two years later, a group of anaesthetists evaluated the dolorimeter as an instrument for assessing pain, principally in pain clinic patients. They conducted over a hundred hours of testing on themselves and reported, "On occasions we have submitted to exposures of this kind for from twenty to forty minutes. Such exposures produced deep burns that took a long time to heal, but we were convinced that there was such a thing as a ceiling for pain..." 7 . They concluded that the dolorimeter may have application as a tool for evaluating analgesic drugs, but felt it had little application as a measuring tool in patients.
The main critic of the dolorimeter was Henry Beecher, Professor and Chair of the Department of Anesthesia at Massachusetts General Hospital. Beecher insisted that pain research could be carried out only by studying real pain in patients, taking into account all the subjective, emotional overlays that accompanied the origins of the pain. His work in the field of pain measurement was extensive and it was one of the many areas where he tried to quantify subjective responses 8 . His randomised, blinded trials involved the use of placebos, then a very new concept, and a crossover design where the patients served as their own controls, receiving two or more analgesics during a given painful episode 9 . They measured a single response, the presence of a 50% reduction in pain. Beecher's meticulous methodology became the foundation for future research into clinical pain management and analgesic efficacy.
Almost a decade later, Ronald Melzack and Warren Torgerson created a five-point verbal scale from mild to excruciating. They also validated a number of descriptive words to create a "language of pain", acceptable terminology which could be used by all clinicians 10 . In 1975, Melzack combined these to produce the McGill Pain Questionnaire which became an important tool in the study of clinical pain 11 . Paralleling these developments, in 1966, Michael Bond and Issy Pilowsky, psychiatrists in Sheffield in the UK, described the visual analogue scale (VAS), a 10 cm line labelled "no pain" at one end and "severe pain at the other" 12 . A numerical rating scale followed, expressing pain in terms of intensity on a scale of 0 to 10. These and other similar methods produced a measurement which could be documented in the patient history and provide a means of assessing analgesic efficacy.
There are limitations to these simple measurement techniques but their introduction heralded an improvement in the attitude to pain management, culminating in the inclusion of a pain score on the nursing observations chart. Nursing literature in the late 1990s referred to this as the "fifth vital sign" 13 . These simple tests remain clinically useful today but pain measurement for research purposes has become more complex: current European guidelines require multiple end-points to be considered, such as time to pain relief, time to onset and duration of analgesia, functional performance, etc. 14, 15 . Despite their complexity, the publication of such guidelines goes a long way to facilitating co-operative research, developing improved pain measurement tools, discovering better treatment options and, ultimately, a comprehensive understanding of "the language of pain".
